Other OTC Pharmaceuticals - Southeast Asia

Southeast Asia

Highlights

In Southeast Asia, the revenue generated in the Other OTC Pharmaceuticals market amounts to US$1.16bn in 2024.
It is projected that the market will experience an annual growth rate of 2.24% (CAGR 2024-2029).
When compared to other countries worldwide, the United States leads in terms of revenue, generating US$7.17bn in 2024.
In terms of per capita revenue, in Southeast Asia generates US$1.67 per person in 2024.
In Southeast Asia, the demand for Other OTC Pharmaceuticals is rising due to the increasing awareness and adoption of self-medication practices.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in Southeast Asia is experiencing steady growth due to increasing customer preferences for self-medication, growing awareness about the benefits of OTC medications, and favorable local special circumstances.Customer preferences in the Southeast Asian region are shifting towards self-medication, driven by factors such as convenience, cost-effectiveness, and easy accessibility of OTC pharmaceuticals. Consumers are increasingly seeking quick relief from common ailments such as headaches, colds, and allergies, and are opting for OTC medications instead of visiting healthcare professionals. This trend is further supported by the availability of a wide range of OTC products in pharmacies, supermarkets, and online platforms, providing customers with a variety of options to choose from.Trends in the market show that Southeast Asian consumers are becoming more aware of the benefits of OTC medications. They are increasingly relying on self-diagnosis and self-treatment for minor ailments, which has led to an increased demand for OTC pharmaceuticals. The growing middle-class population in the region, along with rising disposable incomes, has also contributed to the increased affordability of OTC medications. Moreover, the expansion of organized retail and e-commerce channels has made it easier for consumers to access a wide range of OTC products, further driving market growth.Local special circumstances in Southeast Asia, such as the prevalence of tropical diseases and the high cost of healthcare, have also contributed to the growth of the Other OTC Pharmaceuticals market. The region is known for its high incidence of diseases such as dengue fever, malaria, and respiratory infections, which often require immediate treatment. OTC pharmaceuticals provide a convenient and cost-effective solution for consumers to manage these conditions without the need for a prescription or a visit to a healthcare professional. Additionally, the high cost of healthcare services in some Southeast Asian countries makes OTC medications a more affordable option for consumers.Underlying macroeconomic factors, such as population growth, urbanization, and increasing healthcare expenditure, are driving the growth of the Other OTC Pharmaceuticals market in Southeast Asia. The region has a large and growing population, with a significant proportion residing in urban areas. Urbanization and the associated lifestyle changes have led to an increased prevalence of lifestyle-related ailments, such as obesity, diabetes, and hypertension, which can be managed through OTC medications. Furthermore, governments in the region are increasing their healthcare expenditure to improve access to healthcare services, including OTC medications, for their populations.In conclusion, the Other OTC Pharmaceuticals market in Southeast Asia is growing due to customer preferences for self-medication, increasing awareness about the benefits of OTC medications, favorable local special circumstances, and underlying macroeconomic factors. The market is expected to continue its growth trajectory in the coming years, driven by the evolving healthcare landscape and changing consumer behaviors in the region.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.